Evaluation & Cost Effectiveness of HIV Prevention in Asia

Date Commenced:
09/2011
Project Status
Ongoing
Expected Date of Completion:
12/2013
Project Supporters

The World Bank

Currently recruiting
Yes
image - Kirby Logo On White 49

About the Project

Rationale

We are informing strategy and resource allocations in Asia (and Eastern Europe). This study is expected to result in better decision-making by governments on more cost-effective implementation of HIV prevention programmes in Asia, and to contribute to the global body of knowledge about HIV prevention cost-effectiveness in concentrated epidemics.

Aims

The key objective of this assignment is to contribute to the improvement of the effectiveness and efficiency of HIV prevention responses in Asia’s concentrated HIV epidemic settings.  The study is providing evidence on the epidemiological impact of HIV prevention programmes and their cost-effectiveness, based on the systematic design and conduct of impact evaluation trials, collection of data, modeling, health economic analyses and assessment of potential mismatches that exist between investment in targeted preventions and HIV epidemiology. Rigorous analysis and synthesis of the major risk factors and drivers of the epidemics, reinforced by an equally rigorous review of the evidence-base for various HIV interventions and the respective investments will be conducted.

Design & Method

We are drawing on the data and experiences from 8-12 countries in East Asia & Pacific (EAP), Europe & Central Asia (ECA) and the South Asia Region (SAR). Engaging with in-country partners, and applying rigorous data collection, modeling, impact evaluation, resource assessment and health economic techniques, we are assisting these countries to know their epidemics better, understand what results and cost-effectiveness outcomes have been achieved through targeted (and non-targeted) interventions and what returns have likely been obtained on HIV investments. We are informing policy and programme officials in these settings on the expected relative epidemiological and cost-effectiveness implications associated with future potential implementations of different targeted population-level interventions at realistic coverage levels. These interventions are assessed solely and in combinations. We are also designing and conducting empirical bio-behavioural cross-sectional and cohort trials.

Progress/Update

Data collection is complete for background reviews, economic analyses are underway, trial designs are complete.

Benefits

HIV/AIDS effectiveness evaluation and cost-effectiveness studies have become important analytical tools to understand what HIV investments have bought, whether the interventions averted new infections and AIDS deaths, and at what cost. They can support decision-making and prioritisationof intervention strategies and target groups within the HIV/AIDS response with its overall goals of minimising the burden of disease and maximising health outcomes.

Output

In Asia, the HIV epidemics are concentrated, driven by the prevalence of risky practices such as injecting drug use (IDU) and unprotected sex among sex workers and their sexual contacts. Drawing from data and experiences from countries in East Asia & Pacific, Europe & central Asia and the South Asia Region, this study will contribute to the improvement of the effectiveness and efficiency of HIV prevention responses in Asia’s concentrated HIV epidemic settings.

Project Members
image - David Wilson 1
Conjoint Associate Professor
Ph +61 (0)2 9385 0900
image - 1338434091 Lei Zhang
Visiting Senior Research Fellow
Ph +61 (2) 9385 0875
image - 1338434124 Richard Gray Sepph
Senior Lecturer
Ph +61 (0)2 9385 0925
image - 1344993424 Cliff Kerr
Research Assistant
Ph +61 (0)2 9385 0900
image - 1338434240 Alex Hoare
Dr Alexander Hoare
Research Assistant
image - Josephine Reyes 03065249
Associate lecturer
Ph +61 (0)2 9385 2501
image - 1353456838 Eric Chow Replace
Research Assistant
Ph +61 (0)2 9385 0900
image - Quang Duy Pham SEPPH
PhD student
Ph +61 (0)2 9385 0900
image - 1338435195 Ka Lan Lu
Research Assistant
Ph +61 (0)2 9385 0900
image - 1338434959 Dam Anh Tran Sepph
Research Assistant
Ph +61 (0)2 9385 0239
image - Kirby Logo On White 5
Graduate PhD Student
Ph +61 (0)2 9385 0900
image - 1338434303 Amy Kwon Sepph
Research Associate
Ph +61 (0)2 9385 0952
image - 1344993298 Karen Schneider Ar09
Research Officer
Ph +61 (0)2 9385 0900
image - 1340669445 Andrew Craig
Research Assistant
Ph +61 2 9385 9212
image - 1338434600 Megan Tapia
Program Coordinator
Ph +61 (0)2 9385 0900
Dr Xun Zhuang
Visiting Fellow
Other Investigators

Karina Razali, Ines Yap

Project Collaborators: External

World Bank Global HIV/AIDS Program

National Center for AIDS Prevention and Control

Nantong University

Tsinghua University

University of Indonesia

Indonesia National AIDS Commission

Indonesian Ministry of Health

University of Malaya

Malaysian Ministry of Health

Malaysian AIDS Council

Malaysia National Anti-Drug Agency

Royal Malaysian Police

Malaysian Prison Department

National Epidemiology Center, Department of Health, Philippines

World Health Organization

HIV-NAT (HIV-Netherlands-Australia-Thailand) Research Collaboration

Thai Ministry of Health

Viet Nam Administration of HIV/AIDS Control

UNAIDS

Pasteur Institute

National Drug and Alcohol Research Centre, UNSW

School of Public Health and Community Medicine, UNSW

HART Consulting

Yale University

Philippines National AIDS Council

AIDS Projects Management Group

Hanoi School of Public Health

Mai Hoa Do Consulting

China National Center for AIDS/STD Control and Prevention

USAID

Alliance Ukraine